Skip to search formSkip to main contentSkip to account menu

GALACTOSIALIDOSIS

Known as: GSL, Lysosomal protective protein, deficiency of, Neuraminidase deficiency with beta-galactosidase deficiency 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Graphene superlattices (GSLs), formed by subjecting a monolayer graphene sheet to a periodic potential, can be used to engineer… 
2010
2010
Facile CuI-mediated N-arylation of diketopiperazine using the Fukuyama modification of the Ullmann-Goldberg reaction can be… 
Highly Cited
2000
Highly Cited
2000
Endothelin‐1 is a peptidic substrate in vitro of lysosomal protective protein/cathepsin A (PPCA) with serine carboxypeptidase… 
Highly Cited
1999
Highly Cited
1999
Latent membrane protein 1 (LMP1) is an Epstein‐Barr virus (EBV) protein expressed in EBV‐transformed B lymphocytes and in… 
Highly Cited
1998
Highly Cited
1998
Previously, we showed that the addition of human erythrocyte glycosphingolipids (GSLs) to nonhuman CD4(+) or GSL-depleted human… 
1995
1995
In previous studies of the glutamine synthetase gene, the promoter and two enhancer elements, one in the upstream region and one… 
1985
1985
AbstractTwenty-two patients with galactosialidosis were studied from clinical, biochemical, and genetic standpoints. A wide… 
1983
1983
Functionally defined clones and lines of murine lymphocytes including myelomas, helper, suppressor and cytolytic T lymphocytes…